KRAS and pancreatic neoplasm: Interestingly, it appears that PDE4D regulates mTORC1 activity, cell size, and cell proliferation in KRAS-mutant (AsPC-1) compared with non–KRAS-mutant (BxPC-3) pancreatic cancer cells (Supplemental Figure 8, A–C).